|
1
|
Schwartz AG and Cote ML: Epidemiology of
lung cancer. Adv Exp Med Biol. 893:21–41. 2016. View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar
|
|
3
|
Miller KD, Nogueira L, Mariotto AB,
Rowland JH, Yabroff KR, Alfano CM, Jemal A, Kramer JL and Siegel
RL: Cancer treatment and survivorship statistics, 2019. CA Cancer J
Clin. 69:363–385. 2019. View Article : Google Scholar
|
|
4
|
Xiong Y, Huang BY and Yin JY:
Pharmacogenomics of platinum- based chemotherapy in non- small cell
lung cancer: Focusing on DNA repair systems. Med Oncol. 34:482017.
View Article : Google Scholar
|
|
5
|
Denisenko TV, Budkevich IN and Zhivotovsky
B: Cell death- based treatment of lung adenocarcinoma. Cell Death
Dis. 9:1172018. View Article : Google Scholar
|
|
6
|
Zhao J, Xu T, Wang F, Cai W and Chen L:
miR- 493-5p suppresses hepatocellular carcinoma cell proliferation
through targeting GP73. Biomed Pharmacother. 90:744–751. 2017.
View Article : Google Scholar
|
|
7
|
Yu X and Li Z: MicroRNA expression and its
implications for diagnosis and therapy of tongue squamous cell
carcinoma. J Cell Mol Med. 20:10–16. 2016. View Article : Google Scholar
|
|
8
|
Gao Y, Luo LH, Li S and Yang C: miR- 17
inhibitor suppressed osteosarcoma tumor growth and metastasis via
increasing PTEN expression. Biochem Biophys Res Commun.
444:230–234. 2014. View Article : Google Scholar
|
|
9
|
Yue LU, Xiang JY, Sun P, Yao YS, Sun ZN,
Liu XP, Wang HB, Shen Z and Yao RY: Relationship between HSP70 and
ERBB2 expression in breast cancer cell lines regarding drug
resistance. Anticancer Res. 36:1243–1249. 2016.
|
|
10
|
Yu X, Li Z, Chan MT and Wu WK: microRNA
deregulation in keloids: An opportunity for clinical intervention?
Cell Prolif. 48:626–630. 2015. View Article : Google Scholar
|
|
11
|
Pan JY, Zhang F, Sun CC, Li SJ, Li G, Gong
FY, Bo T, He J, Hua RX, Hu WD, et al: miR- 134: A human cancer
suppressor? Mol Ther Nucleic Acids. 6:140–149. 2017. View Article : Google Scholar
|
|
12
|
Cao Q, Liu F, Ji K, Liu N, He Y, Zhang W
and Wang L: MicroRNA- 381 inhibits the metastasis of gastric cancer
by targeting TMEM16A expression. J Exp Clin Cancer Res. 36:292017.
View Article : Google Scholar
|
|
13
|
Yu X, Li Z, Yu J, Chan MTV and Wu WKK:
MicroRNAs predict and modulate responses to chemotherapy in
colorectal cancer. Cell Prolif. 48:503–510. 2015. View Article : Google Scholar
|
|
14
|
Pei K, Zhu JJ, Wang CE, Xie QL and Guo JY:
MicroRNA- 185-5p modulates chemosensitivity of human non- small
cell lung cancer to cisplatin via targeting ABCC1. Eur Rev Med
Pharmacol Sci. 20:4697–4704. 2016.
|
|
15
|
Yu S, Qin X, Chen T, Zhou L, Xu X and Feng
J: MicroRNA- 106b-5p regulates cisplatin chemosensitivity by
targeting polycystic kidney disease- 2 in non- small- cell lung
cancer. Anticancer Drugs. 28:852–860. 2017. View Article : Google Scholar
|
|
16
|
Gang H, Pan J, Ye Z, Fang B and Wei C:
Overexpression of miR- 216b sensitizes NSCLC cells to cisplatin-
induced apoptosis by targeting c- Jun. Oncotarget. 8:104206–104215.
2017. View Article : Google Scholar
|
|
17
|
Azarbarzin S, Feizi MAH, Safaralizadeh R,
Kazemzadeh M and Fateh A: The value of miR- 383, an intronic miRNA,
as a diagnostic and prognostic biomarker in intestinal- type
gastric cancer. Biochem Genet. 55:244–252. 2017. View Article : Google Scholar
|
|
18
|
Bucay N, Sekhon K, Yang T, Majid S,
Shahryari V, Hsieh C, Mitsui Y, Deng G, Tabatabai ZL, Yamamura S,
et al: MicroRNA- 383 located in frequently deleted chromosomal
locus 8p22 regulates CD44 in prostate cancer. Oncogene.
36:2667–2679. 2017. View Article : Google Scholar
|
|
19
|
Shang Y, Zang A, Li J, Jia Y, Li X, Zhang
L, Huo R, Yang J, Feng J, Ge K, et al: MicroRNA- 383 is a tumor
suppressor and potential prognostic biomarker in human non- small
cell lung caner. Biomed Pharmacother. 83:1175–1181. 2016.
View Article : Google Scholar
|
|
20
|
Ma H, Liu B, Wang S and Liu J: MicroRNA-
383 is a tumor suppressor in human lung cancer by targeting
endothelial PAS domain- containing protein 1. Cell Biochem Funct.
34:613–619. 2016. View Article : Google Scholar
|
|
21
|
Tan W, Liao Y, Qiu Y, Liu H, Tan D, Wu T,
Tang M, Zhang S and Wang H: miRNA 146a promotes chemotherapy
resistance in lung cancer cells by targeting DNA damage inducible
transcript 3 (CHOP). Cancer Lett. 428:55–68. 2018. View Article : Google Scholar
|
|
22
|
Wagenaar SS: New WHO- classification of
lung and pleural tumors. Ned Tijdschr Geneeskd. 143:984–990.
1999.In Dutch.
|
|
23
|
Tsim S, O'Dowd CA, Milroy R and Davidson
S: Staging of non- small cell lung cancer (NSCLC): A review. Respir
Med. 104:1767–1774. 2010. View Article : Google Scholar
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real- time quantitative PCR and
the 2(- Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Lee S, Kopp F, Chang TC, Sataluri A, Chen
B, Sivakumar S, Yu H, Xie Y and Mendell JT: Noncoding RNA NORAD
regulates genomic stability by sequestering PUMILIO proteins. Cell.
164:69–80. 2016. View Article : Google Scholar
|
|
26
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the Care and Use of Laboratory Animals. 8th
edition. National Academies Press; Washington DC: 2011
|
|
27
|
Shanker M, Willcutts D, Roth JA and Ramesh
R: Drug resistance in lung cancer. Lung Cancer (Auckl). 1:23–36.
2010.
|
|
28
|
Panwar B, Omenn GS and Guan Y: miRmine: A
database of human miRNA expression profiles. Bioinformatics.
33:1554–1560. 2017.
|
|
29
|
Ludwig N, Leidinger P, Becker K, Backes C,
Fehlmann T, Pallasch C, Rheinheimer S, Meder B, Stähler C, Meese E
and Keller A: Distribution of miRNA expression across human
tissues. Nucleic Acids Res. 44:3865–3877. 2016. View Article : Google Scholar
|
|
30
|
Wan P, Chi X, Du Q, Luo J, Cui X, Dong K,
Bing Y, Heres C and Geller DA: miR-383 promotes cholangiocarcinoma
cell proliferation, migration, and invasion through targeting IRF1.
J Cell Biochem. 119:9720–9729. 2018. View Article : Google Scholar
|
|
31
|
Dong P, Xiong Y, Yu J, Chen L, Tao T, Yi
S, Hanley SJB, Yue J, Watari H and Sakuragi N: Correction: Control
of PD- L1 expression by miR- 140/142/340/383 and oncogenic
activation of the OCT4- miR- 18a pathway in cervical cancer.
Oncogene. 38:39722019. View Article : Google Scholar
|
|
32
|
Zhao S, Gao X, Zang S, Li Y, Feng X and
Yuan X: MicroRNA- 383-5p acts as a prognostic marker and inhibitor
of cell proliferation in lung adenocarcinoma by cancerous inhibitor
of protein phosphatase 2A. Oncol Lett. 14:3573–3579. 2017.
View Article : Google Scholar
|
|
33
|
Mu X, Wu H, Liu J, Hu X, Wu H, Chen L, Liu
W, Luo S and Zhao Y: Long noncoding RNA TMPO- AS1 promotes lung
adenocarcinoma progression and is negatively regulated by miR-
383-5p. Biomed Pharmacother. 125:1099892020. View Article : Google Scholar
|
|
34
|
Piovani G, Savio G, Traversa M, Pilotta A,
De Petro G, Barlati S and Magri C: De novo 1Mb interstitial
deletion of 8p22 in a patient with slight mental retardation and
speech delay. Mol Cytogenet. 7:252014. View Article : Google Scholar
|
|
35
|
Chi C, Murphy LC and Hu P: Recurrent copy
number alterations in young women with breast cancer. Oncotarget.
9:11541–11558. 2018. View Article : Google Scholar
|
|
36
|
Tsubaki M, Ogawa N, Takeda T, Sakamoto K,
Shimaoka H, Fujita A, Itoh T, Imano M, Satou T and Nishida S:
Dimethyl fumarate induces apoptosis of hematopoietic tumor cells
via inhibition of NF-κB nuclear translocation and down- regulation
of Bcl- xL and XIAP. Biomed Pharmacother. 68:999–1005. 2014.
View Article : Google Scholar
|
|
37
|
Viatour P, Merville MP, Bours V and
Chariot A: Phosphorylation of NF- kappaB and IkappaB proteins:
Implications in cancer and inflammation. Trends Biochem Sci.
30:43–52. 2005. View Article : Google Scholar
|
|
38
|
Chen Y, Wang D, Peng H, Chen X, Han X, Yu
J, Wang W, Liang L, Liu Z, Zheng Y, et al: Epigenetically
upregulated oncoprotein PLCE1 drives esophageal carcinoma
angiogenesis and proliferation via activating the PI- PLCε- NF-κB
signaling pathway and VEGF- C/Bcl- 2 expression. Mol Cancer.
18:12019. View Article : Google Scholar
|
|
39
|
Bravo-Cuellar A, Hernández- Flores G,
Lerma- Díaz JM, Domínguez- Rodríguez JR, Jave-Suárez LF, De Célis-
Carrillo R, Aguilar- Lemarroy A, Gómez-Lomeli P and Ortiz-Lazareno
PC: Pentoxifylline and the proteasome inhibitor MG132 induce
apoptosis in human leukemia U937 cells through a decrease in the
expression of Bcl- 2 and Bcl- XL and phosphorylation of p65. J
Biomed Sci. 20:132013. View Article : Google Scholar
|
|
40
|
Yao Y, Yang B, Cao H, Zhao K and Chen X:
RBM24 stabilizes hepatitis B virus pregenomic RNA but inhibits core
protein translation by targeting the terminal redundancy sequence.
Emerg Microbes Infect. 7:862018. View Article : Google Scholar
|
|
41
|
Hua WF, Zhong Q, Xia TL, Chen Q, Zhang MY,
Zhou AJ, Tu ZW, Qu C, Li MZ, Xia YF, et al: RBM24 suppresses cancer
progression by upregulating miR- 25 to target MALAT1 in
nasopharyngeal carcinoma. Cell Death Dis. 7:e23522016. View Article : Google Scholar
|
|
42
|
Xu E, Zhang J, Zhang M, Jiang Y, Cho SJ
and Chen X: RNA- binding protein RBM24 regulates p63 expression via
mRNA stability. Mol Cancer Res. 12:359–369. 2014. View Article : Google Scholar
|
|
43
|
Zhang Q, Wang YZ, Zhang W, Chen X, Wang J,
Chen J and Luo W: Involvement of cold inducible RNA- binding
protein in severe hypoxia- induced growth arrest of neural stem
cells in vitro. Mol Neurobiol. 54:2143–2153. 2016. View Article : Google Scholar
|
